Texas 2023 - 88th Regular

Texas House Bill HB2411 Latest Draft

Bill / Engrossed Version Filed 04/20/2023

Download
.pdf .doc .html
                            88R20867 CXP-F
 By: Talarico, Oliverson, Leo-Wilson, Howard, H.B. No. 2411
 Zwiener, et al.


 A BILL TO BE ENTITLED
 AN ACT
 relating to the maintenance, administration, and disposal of opioid
 antagonists on public and private school campuses and to the
 permissible uses of money appropriated to a state agency from the
 opioid abatement account.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Chapter 38, Education Code, is amended by adding
 Subchapter E-1 to read as follows:
 SUBCHAPTER E-1. MAINTENANCE, ADMINISTRATION, AND DISPOSAL OF
 OPIOID ANTAGONISTS
 Sec. 38.221.  DEFINITIONS. In this subchapter:
 (1)  "Opioid antagonist" and "opioid-related drug
 overdose" have the meanings assigned by Section 483.101, Health and
 Safety Code.
 (2)  "Physician" means a person who holds a license to
 practice medicine in this state.
 Sec. 38.222.  MAINTENANCE, ADMINISTRATION, AND DISPOSAL OF
 OPIOID ANTAGONISTS.  (a)  Each school district shall adopt and
 implement a policy regarding the maintenance, administration, and
 disposal of opioid antagonists at each campus in the district that
 serves students in grades 6 through 12 and may adopt and implement
 such a policy at each campus in the district, including campuses
 serving students in a grade level below grade 6.
 (b)  An open-enrollment charter school or private school may
 adopt and implement a policy regarding the maintenance,
 administration, and disposal of opioid antagonists.  If a school
 adopts a policy under this subsection, the school may apply the
 policy:
 (1)  only at campuses of the school serving students in
 grades 6 through 12; or
 (2)  at each campus of the school, including campuses
 serving students in a grade level below grade 6.
 (c)  A policy adopted under this section must:
 (1)  provide that school personnel and school
 volunteers who are authorized and trained may administer an opioid
 antagonist to a person who is reasonably believed to be
 experiencing an opioid-related drug overdose;
 (2)  require that each school campus subject to a
 policy adopted under this section have one or more school personnel
 members or school volunteers authorized and trained to administer
 an opioid antagonist present during regular school hours;
 (3)  establish the number of opioid antagonists that
 must be available at each campus at any given time; and
 (4)  require that the supply of opioid antagonists at
 each school campus subject to a policy adopted under this section
 must be stored in a secure location and be easily accessible to
 school personnel and school volunteers authorized and trained to
 administer an opioid antagonist.
 (d)  The executive commissioner of the Health and Human
 Services Commission, in consultation with the commissioner of
 education, shall adopt rules regarding the maintenance,
 administration, and disposal of opioid antagonists at a school
 campus subject to a policy adopted under this section.  The rules
 must establish:
 (1)  the process for checking the inventory of opioid
 antagonists at regular intervals for expiration and replacement;
 and
 (2)  the amount of training required for school
 personnel and school volunteers to administer an opioid antagonist.
 Sec. 38.223.  REPORT ON ADMINISTERING OPIOID ANTAGONIST.
 (a)  Not later than the 10th business day after the date a school
 personnel member or school volunteer administers an opioid
 antagonist in accordance with a policy adopted under Section
 38.222(a) or (b), the school shall report the information required
 under Subsection (b) of this section to:
 (1)  the school district, the charter holder if the
 school is an open-enrollment charter school, or the governing body
 of the school if the school is a private school;
 (2)  the physician or other person who prescribed the
 opioid antagonist; and
 (3)  the commissioner of state health services.
 (b)  The report required under this section must include the
 following information:
 (1)  the age of the person who received the
 administration of the opioid antagonist;
 (2)  whether the person who received the administration
 of the opioid antagonist was a student, a school personnel member or
 school volunteer, or a visitor;
 (3)  the physical location where the opioid antagonist
 was administered;
 (4)  the number of doses of opioid antagonist
 administered;
 (5)  the title of the person who administered the
 opioid antagonist; and
 (6)  any other information required by the commissioner
 of education.
 Sec. 38.224.  TRAINING.  (a)  Each school district,
 open-enrollment charter school, and private school that adopts a
 policy under Section 38.222(a) or (b) is responsible for training
 school personnel and school volunteers in the administration of an
 opioid antagonist.
 (b)  Training required under this section must:
 (1)  include information on:
 (A)  recognizing the signs and symptoms of an
 opioid-related drug overdose;
 (B)  administering an opioid antagonist;
 (C)  implementing emergency procedures, if
 necessary, after administering an opioid antagonist; and
 (D)  properly disposing of used or expired opioid
 antagonists;
 (2)  be provided in a formal training session or
 through online education; and
 (3)  be provided in accordance with the policy adopted
 under Section 21.4515.
 (c)  Each school district, open-enrollment charter school,
 or private school that adopts a policy under Section 38.222(a) or
 (b) must maintain records on the training required under this
 section.
 Sec. 38.225.  PRESCRIPTION OF OPIOID ANTAGONISTS.  (a)  A
 physician or person who has been delegated prescriptive authority
 under Chapter 157, Occupations Code, may prescribe opioid
 antagonists in the name of a school district, open-enrollment
 charter school, or private school.
 (b)  A physician or other person who prescribes opioid
 antagonists under Subsection (a) shall provide the school district,
 open-enrollment charter school, or private school with a standing
 order for the administration of an opioid antagonist to a person
 reasonably believed to be experiencing an opioid-related drug
 overdose.
 (c)  The standing order under Subsection (b) is not required
 to be patient-specific, and the opioid antagonist may be
 administered to a person without a previously established
 physician-patient relationship.
 (d)  Notwithstanding any other provisions of law,
 supervision or delegation by a physician is considered adequate if
 the physician:
 (1)  periodically reviews the order; and
 (2)  is available through direct telecommunication as
 needed for consultation, assistance, and direction.
 (e)  An order issued under this section must contain:
 (1)  the name and signature of the prescribing
 physician or other person;
 (2)  the name of the school district, open-enrollment
 charter school, or private school to which the order is issued;
 (3)  the quantity of opioid antagonists to be obtained
 and maintained under the order; and
 (4)  the date of issue.
 (f)  A pharmacist may dispense an opioid antagonist to a
 school district, open-enrollment charter school, or private school
 without requiring the name or any other identifying information
 relating to the user.
 Sec. 38.226.  GIFTS, GRANTS, AND DONATIONS. A school
 district, open-enrollment charter school, or private school may
 accept gifts, grants, donations, and federal and local funds to
 implement this subchapter.
 Sec. 38.227.  IMMUNITY FROM LIABILITY. (a) A person who in
 good faith takes, or fails to take, any action under this subchapter
 is immune from civil or criminal liability or disciplinary action
 resulting from that action or failure to act, including:
 (1)  issuing an order for opioid antagonists;
 (2)  supervising or delegating the administration of an
 opioid antagonist;
 (3)  possessing, maintaining, storing, or disposing of
 an opioid antagonist;
 (4)  prescribing an opioid antagonist;
 (5)  dispensing an opioid antagonist;
 (6)  administering, or assisting in administering, an
 opioid antagonist;
 (7)  providing, or assisting in providing, training,
 consultation, or advice in the development, adoption, or
 implementation of policies, guidelines, rules, or plans; or
 (8)  undertaking any other act permitted or required
 under this subchapter.
 (b)  The immunities and protections provided by this
 subchapter are in addition to other immunities or limitations of
 liability provided by law.
 (c)  Notwithstanding any other law, this subchapter does not
 create a civil, criminal, or administrative cause of action or
 liability or create a standard of care, obligation, or duty that
 provides a basis for a cause of action for an act or omission under
 this subchapter.
 (d)  A cause of action does not arise from an act or omission
 described by this section.
 (e)  A school district, open-enrollment charter school, or
 private school and school personnel and school volunteers are
 immune from suit resulting from an act, or failure to act, under
 this subchapter, including an act or failure to act under related
 policies and procedures.
 (f)  An act or failure to act by school personnel or a school
 volunteer under this subchapter, including an act or failure to act
 under related policies and procedures, is the exercise of judgment
 or discretion on the part of the school personnel or school
 volunteer and is not considered to be a ministerial act for purposes
 of liability of the school district, open-enrollment charter
 school, or private school.
 Sec. 38.228.  RULES. Except as otherwise provided by this
 subchapter, the commissioner of education and the executive
 commissioner of the Health and Human Services Commission shall
 jointly adopt rules necessary to implement this subchapter.
 SECTION 2.  Section 403.505(d), Government Code, is amended
 to read as follows:
 (d)  A state agency may use money appropriated from the
 account only to:
 (1)  prevent opioid use disorder through
 evidence-based education and prevention, such as school-based
 prevention, early intervention, or health care services or programs
 intended to reduce the risk of opioid use by school-age children;
 (2)  support efforts to prevent or reduce deaths from
 opioid overdoses or other opioid-related harms, including through
 increasing the availability or distribution of naloxone or other
 opioid antagonists for use by:
 (A)  health care providers;
 (B)  [,] first responders;
 (C)  [,] persons experiencing an opioid overdose;
 (D)  [,] families;
 (E)  [,] schools, including under a policy adopted
 under Subchapter E-1, Chapter 38, Education Code, regarding the
 maintenance, administration, and disposal of opioid antagonists;
 (F)  community-based service providers;
 (G)  [,] social workers;[,] or
 (H)  other members of the public;
 (3)  create and provide training on the treatment of
 opioid addiction, including the treatment of opioid dependence with
 each medication approved for that purpose by the United States Food
 and Drug Administration, medical detoxification, relapse
 prevention, patient assessment, individual treatment planning,
 counseling, recovery supports, diversion control, and other best
 practices;
 (4)  provide opioid use disorder treatment for youths
 and adults, with an emphasis on programs that provide a continuum of
 care that includes screening and assessment for opioid use disorder
 and co-occurring behavioral health disorders, early intervention,
 contingency management, cognitive behavioral therapy, case
 management, relapse management, counseling services, and
 medication-assisted treatments;
 (5)  provide patients suffering from opioid dependence
 with access to all medications approved by the United States Food
 and Drug Administration for the treatment of opioid dependence and
 relapse prevention following opioid detoxification, including
 opioid agonists, partial agonists, and antagonists;
 (6)  support efforts to reduce the abuse or misuse of
 addictive prescription medications, including tools used to give
 health care providers information needed to protect the public from
 the harm caused by improper use of those medications;
 (7)  support treatment alternatives that provide both
 psychosocial support and medication-assisted treatments in areas
 with geographical or transportation-related challenges, including
 providing access to mobile health services and telemedicine,
 particularly in rural areas;
 (8)  address:
 (A)  the needs of persons involved with criminal
 justice; and
 (B)  rural county unattended deaths; or
 (9)  further any other purpose related to opioid
 abatement authorized by appropriation.
 SECTION 3.  Not later than November 1, 2023:
 (1)  the executive commissioner of the Health and Human
 Services Commission shall, in consultation with the commissioner of
 education, adopt rules required under Section 38.222, Education
 Code, as added by this Act; and
 (2)  the commissioner of education and the executive
 commissioner of the Health and Human Services Commission shall
 jointly adopt rules necessary to implement Subchapter E-1, Chapter
 38, Education Code, as added by this Act.
 SECTION 4.  Notwithstanding the effective date of this Act,
 a school district is not required to comply with Section 38.222,
 Education Code, as added by this Act, before January 1, 2024.
 SECTION 5.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2023.